Janus Henderson Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.4M Sell
15,143
-873
-5% -$218K ﹤0.01% 1102
2025
Q4
$3.86M Sell
16,016
-806
-5% -$206K ﹤0.01% 1032
2025
Q3
$4.61M Sell
16,822
-653
-4% -$178K ﹤0.01% 946
2025
Q2
$4.5M Buy
17,475
+540
+3% +$129K ﹤0.01% 939
2025
Q1
$3.72M Buy
16,935
+128
+0.8% +$29.9K ﹤0.01% 990
2024
Q4
$3.85M Buy
16,807
+647
+4% +$156K ﹤0.01% 1011
2024
Q3
$3.94M Buy
16,160
+296
+2% +$66.1K ﹤0.01% 982
2024
Q2
$3.04M Sell
15,864
-3,652
-19% -$741K ﹤0.01% 1060
2024
Q1
$3.86M Buy
19,516
+902
+5% +$165K ﹤0.01% 978
2023
Q4
$3.2M Sell
18,614
-116
-0.6% -$17.8K ﹤0.01% 1010
2023
Q3
$2.77M Sell
18,730
-1,660
-8% -$300K ﹤0.01% 1022
2023
Q2
$4.46M Sell
20,390
-2,105
-9% -$469K ﹤0.01% 894
2023
Q1
$4.92M Buy
22,495
+4,673
+26% +$1.01M ﹤0.01% 877
2022
Q4
$3.71M Sell
17,822
-17,824
-50% -$3.92M ﹤0.01% 933
2022
Q3
$7.79M Buy
35,646
+16,981
+91% +$3.87M ﹤0.01% 887
2022
Q2
$3.92M Sell
18,665
-1,089,350
-98% -$232M ﹤0.01% 883
2022
Q1
$269M Sell
1,108,015
-216,416
-16% -$52.3M 0.13% 175
2021
Q4
$345M Sell
1,324,431
-184,943
-12% -$48M 0.14% 161
2021
Q3
$398M Sell
1,509,374
-37,978
-2% -$10.4M 0.17% 131
2021
Q2
$381M Sell
1,547,352
-179,449
-10% -$37.7M 0.16% 147
2021
Q1
$335M Buy
1,726,801
+476,477
+38% +$95.5M 0.15% 158
2020
Q4
$266M Sell
1,250,324
-227,367
-15% -$45.3M 0.12% 177
2020
Q3
$253M Buy
1,477,691
+161,801
+12% +$29.9M 0.13% 166
2020
Q2
$253M Buy
1,315,890
+125,594
+11% +$20.5M 0.14% 164
2020
Q1
$175M Buy
1,190,296
+54,345
+5% +$8.66M 0.12% 188
2019
Q4
$176M Buy
1,135,951
+205,154
+22% +$29.6M 0.09% 242
2019
Q3
$126M Sell
930,797
-65,322
-7% -$8.56M 0.07% 303
2019
Q2
$122M Sell
996,119
-129,335
-11% -$14.3M 0.07% 325
2019
Q1
$117M Buy
1,125,454
+154,863
+16% +$16M 0.06% 341
2018
Q4
$111M Buy
970,591
+707,275
+269% +$75.8M 0.07% 320
2018
Q3
$30.4M Buy
263,316
+102,266
+63% +$11.2M 0.02% 709
2018
Q2
$16.7M Sell
161,050
-53,313
-25% -$5.39M 0.01% 842
2018
Q1
$21.1M Sell
214,363
-47,957
-18% -$4.53M 0.01% 786
2017
Q4
$22.2M Buy
262,320
+55,551
+27% +$4.59M 0.01% 742
2017
Q3
$15.9M Sell
206,769
-15,879
-7% -$1.21M 0.01% 782
2017
Q2
$17.3M Buy
222,648
+205,596
+1,206% +$14.7M 0.01% 773
2017
Q1
$1.23M Hold
17,052
0.01% 628
2016
Q4
$1.06M Buy
17,052
+2,000
+13% +$122K 0.01% 660
2016
Q3
$975K Buy
15,052
+5,830
+63% +$388K 0.01% 655
2016
Q2
$583K Sell
9,222
-5,746
-38% -$339K ﹤0.01% 733
2016
Q1
$866K Hold
14,968
0.01% 678
2015
Q4
$804K Hold
14,968
0.01% 679
2015
Q3
$763K Hold
14,968
0.01% 684
2015
Q2
$844K Hold
14,968
0.01% 709
2015
Q1
$1.07M Hold
14,968
0.01% 683
2014
Q4
$839K Hold
14,968
0.01% 727
2014
Q3
$737K Hold
14,968
0.01% 664
2014
Q2
$758K Hold
14,968
0.01% 653
2014
Q1
$669K Buy
14,968
+3,600
+32% +$162K 0.01% 670
2013
Q4
$535K Hold
11,368
0.01% 669
2013
Q3
$601K Hold
11,368
0.01% 649
2013
Q2
$508K Buy
+11,368
New +$539K 0.01% 651

Other funds holding RMD

Janus Henderson Group's RMD Position: Q1 2026 in Review

Janus Henderson Group reduced its ResMed (RMD) stake by 5.5% in Q1 2026, selling an estimated $218K and leaving 15,143 shares worth $3.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Janus Henderson Group first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $398M in Q3 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Janus Henderson Group held 15,143 shares of ResMed worth $3.4M as of Q1 2026.
  • Janus Henderson Group sold 873 ResMed shares in Q1 2026, an estimated $218K.
  • ResMed made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1102 holding.
  • Janus Henderson Group first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Janus Henderson Group's ResMed position peaked at $398M in Q3 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.